Tower Research Capital LLC (Trc) Milestone Pharmaceuticals Inc. Transaction History

Tower Research Capital LLC (Trc)

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.85 - $4.4 $208 - $321	73 Added 73.74%	172 $0
Q1 2023 May 09, 2023	SELL	$3.14 - $4.2 $3,604 - $4,821	-1,148 Reduced 92.06%	99 $0
Q4 2022 Feb 10, 2023	BUY	$3.53 - $9.5 $4,401 - $11,846	1,247 New	1,247 $5,000
Q1 2022 May 12, 2022	SELL	$4.1 - $8.24 $2,275 - $4,573	-555 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.47 - $7.13 $2,231 - $2,909	408 Added 277.55%	555 $4,000
Q3 2021 Nov 15, 2021	SELL	$5.28 - $6.29 $7,492 - $8,925	-1,419 Reduced 90.61%	147 $1,000
Q2 2021 Aug 16, 2021	BUY	$5.22 - $6.11 $8,174 - $9,568	1,566 New	1,566 $9,000
Q1 2021 May 17, 2021	SELL	$5.79 - $8.85 $6,345 - $9,699	-1,096 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.57 - $7.66 $1,002 - $1,378	180 Added 19.65%	1,096 $7,000
Q3 2020 Nov 16, 2020	SELL	$3.34 - $9.8 $5,033 - $14,768	-1,507 Reduced 62.2%	916 $7,000
Q2 2020 Aug 13, 2020	BUY	$1.77 - $4.56 $4,288 - $11,048	2,423 New	2,423 $9,000
Q1 2020 May 15, 2020	SELL	$1.7 - $22.5 $241 - $3,195	-142 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$15.4 - $21.9 $107 - $153	-7 Reduced 4.7%	142 $2,000
Q3 2019 Nov 05, 2019	SELL	$15.67 - $25.96 $27,077 - $44,858	-1,728 Reduced 92.06%	149 $3,000
Q2 2019 Aug 13, 2019	BUY	$15.37 - $27.15 $28,849 - $50,960	1,877 New	1,877 $51,000

28.7M

200

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $61.2M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.